IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 229 filers reported holding IVERIC BIO INC in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $167,981,013 | +592.9% | 4,269,980 | +328.5% | 0.03% | +560.0% |
Q1 2023 | $24,243,920 | -11.4% | 996,462 | -22.0% | 0.01% | -16.7% |
Q4 2022 | $27,349,648 | +41.4% | 1,277,424 | +18.5% | 0.01% | +50.0% |
Q3 2022 | $19,345,000 | +163.6% | 1,078,298 | +41.4% | 0.00% | +100.0% |
Q2 2022 | $7,338,000 | +3.6% | 762,811 | +81.3% | 0.00% | +100.0% |
Q1 2022 | $7,080,000 | +2.4% | 420,696 | +1.7% | 0.00% | 0.0% |
Q4 2021 | $6,914,000 | +130.8% | 413,544 | +124.2% | 0.00% | 0.0% |
Q3 2021 | $2,996,000 | +360.2% | 184,487 | +78.7% | 0.00% | – |
Q2 2021 | $651,000 | +21.5% | 103,245 | +18.9% | 0.00% | – |
Q1 2021 | $536,000 | -90.3% | 86,862 | -89.1% | 0.00% | -100.0% |
Q4 2020 | $5,510,000 | +181.4% | 797,408 | +129.7% | 0.00% | 0.0% |
Q3 2020 | $1,958,000 | -22.6% | 347,197 | -30.0% | 0.00% | 0.0% |
Q2 2020 | $2,531,000 | +444.3% | 496,308 | +266.9% | 0.00% | – |
Q1 2020 | $465,000 | +132.5% | 135,268 | +479.4% | 0.00% | – |
Q4 2019 | $200,000 | +506.1% | 23,347 | -20.5% | 0.00% | – |
Q3 2019 | $33,000 | – | 29,370 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |